Previous studies have reported that overexpression of CCL2 and its receptors, CCR2, and CCR4, in human cancers, promote lung cancer, breast cancer, and HNSCC development via regulation of angiogenesis, cell proliferation, and migration [5, 7–9, 24, 25]. Here, CCR4 is linked to cancer.